|
1
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wistuba II, Behrens C, Milchgrub S, Bryant
D, Hung J, Minna JD and Gazdar AF: Sequential molecular
abnormalities are involved in the multistage development of
squamous cell lung carcinoma. Oncogene. 18:643–650. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cancer Genome Atlas Research Network:
Comprehensive genomic characterization of squamous cell lung
cancers. Nature. 489:519–525. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Imoto I, Izumi H, Yokoi S, Hosoda H,
Shibata T, Hosoda F, Ohki M, Hirohashi S and Inazawa J: Frequent
silencing of the candidate tumor suppressor PCDH20 by epigenetic
mechanism in non-small-cell lung cancers. Cancer Res. 66:4617–4626.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Izumi H, Inoue J, Yokoi S, Hosoda H,
Shibata T, Sunamori M, Hirohashi S, Inazawa J and Imoto I: Frequent
silencing of DBC1 is by genetic or epigenetic mechanisms in
non-small cell lung cancers. Hum Mol Genet. 14:997–1007. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kajiura K, Masuda K, Naruto T, Kohmoto T,
Watabnabe M, Tsuboi M, Takizawa H, Kondo K, Tangoku A and Imoto I:
Frequent silencing of the candidate tumor suppressor TRIM58 by
promoter methylation in early-stage lung adenocarcinoma.
Oncotarget. 8:2890–2905. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Napolitano LM and Meroni G: TRIM family:
Pleiotropy and diversification through homomultimer and
heteromultimer formation. IUBMB Life. 64:64–71. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nisole S, Saieb SA and Saïb A: TRIM family
proteins: Retroviral restriction and antiviral defence. Nat Rev
Microbiol. 3:799–808. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Qiu X, Huang Y, Zhou Y and Zheng F:
Aberrant methylation of TRIM58 in hepatocellular carcinoma and its
potential clinical implication. Oncol Rep. 36:811–818. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Thom CS, Traxler EA, Khandros E, Nickas
JM, Zhou OY, Lazarus JE, Silva AP, Prabhu D, Yao Y, Aribeana C, et
al: Trim58 degrades dynein and regulates terminal erythropoiesis.
Dev Cell. 30:688–700. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
White DE, Rafalskametcalf IU, Ivanov AV,
Corsinotti A, Peng H, Lee SC, Trono D, Janicki SM and Rauscher FJ
III: The ATM substrate KAP1 controls DNA repair in heterochromatin:
Regulation by HP1 proteins and Serine 473/824 phosphorylation. Mol
Cancer Res. 10:401–414. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang X, Zhu H, Snieder H, Su S, Munn D,
Harshfield G, Maria BL, Dong Y, Treiber F, Gutin B and Shi H:
Obesity related methylation changes in DNA of peripheral blood
leukocytes. BMC Med. 8:872010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ritchie ME, Phipson B, Wu D, Hu Y, Law CW,
Shi W and Smyth GK: limma powers differential expression analyses
for RNA-sequencing and microarray studies. Nucleic Acids Res.
43:e472015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bao ZS, Li MY, Wang JY, Zhang CB, Wang HJ,
Yan W, Liu YW, Zhang W, Chen L and Jiang T: Prognostic value of a
nine-gene signature in glioma patients based on mRNA expression
profiling. CNS Neurosci Ther. 20:112–118. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cheng W, Ren X, Cai J, Zhang C, Li M, Wang
K, Liu Y, Han S and Wu A: A five-miRNA signature with prognostic
and predictive value for MGMT promoter-methylated glioblastoma
patients. Oncotarget. 6:29285–29295. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang CB, Zhu P, Yang P, Cai JQ, Wang ZL,
Li QB, Bao ZS, Zhang W and Jiang T: Identification of high risk
anaplastic gliomas by a diagnostic and prognostic signature derived
from mRNA expression profiling. Oncotarget. 6:36643–36651.
2015.PubMed/NCBI
|
|
18
|
Yu G, Wang LG, Han Y and He QY:
clusterProfiler: An R package for comparing biological themes among
gene clusters. OMICS. 16:284–287. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
International Cancer Genome Consortium, .
Hudson TJ, Anderson W, Artez A, Barker AD, Bell C, Bernabé RR, Bhan
MK, Calvo F, Eerola I, et al: International network of cancer
genome projects. Nature. 464:993–998. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gao J, Aksoy BA, Dogrusoz U, Dresdner G,
Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E, et al:
Integrative analysis of complex cancer genomics and clinical
profiles using the cBioPortal. Sci Signal. 6:pl12013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cerami E, Gao J, Dogrusoz U, Gross BE,
Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, et
al: The cBio cancer genomics portal: An open platform for exploring
multidimensional cancer genomics data. Cancer Discov. 2:401–404.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Okada A, Tomasetto C, Lutz Y, Bellocq JP,
Rio MC and Basset P: Expression of matrix metalloproteinases during
rat skin wound healing: Evidence that membrane type-1 matrix
metalloproteinase is a stromal activator of pro-gelatinase A. J
Cell Biol. 137:67–77. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Vaalamo M, Karjalainen-Lindsberg ML,
Puolakkainen P, Kere J and Saarialhokere U: Distinct expression
profiles of stromelysin-2 (MMP-10), collagenase-3 (MMP-13),
macrophage metalloelastase (MMP-12), and tissue inhibitor of
metalloproteinases-3 (TIMP-3) in intestinal ulcerations. Am J
Pathol. 152:1005–1014. 1998.PubMed/NCBI
|
|
24
|
Yen CY, Chen CH, Chang CH, Tseng HF, Liu
SY, Chuang LY, Wen CH and Chang HW: Matrix metalloproteinases (MMP)
1 and MMP10 but not MMP12 are potential oral cancer markers.
Biomarkers. 14:244–249. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Haitina T, Olsson F, Stephansson O, Alsiö
J, Roman E, Ebendal T, Schiöth HB and Fredriksson R: Expression
profile of the entire family of Adhesion G protein-coupled
receptors in mouse and rat. BMC Neurosci. 9:1–14. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Galliano MF, Toulza E, Gallinaro H, Jonca
N, Ishida-Yamamoto A, Serre G and Guerrin M: A novel protease
inhibitor of the alpha2-macroglobulin family expressed in the human
epidermis. J Biol Chemist. 281:5780–5789. 2006. View Article : Google Scholar
|
|
27
|
Vissers LE, Bonetti M, Overman
Paardekooper J, Nillesen WM, Frints SG, de Ligt J, Zampino G,
Justino A, Machado JC, Schepens M, et al: Heterozygous germline
mutations in A2ML1 are associated with a disorder clinically
related to Noonan syndrome. Eur J Hum Genet. 23:317–324. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Nakayama K, Nakayama N, Jinawath N, Salani
R, Kurman RJ, Shih IeM and Wang TL: Amplicon profiles in ovarian
serous carcinomas. Int J Cancer. 120:2613–2617. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Nakayama N, Nakayama K, Shamima Y,
Ishikawa M, Katagiri A, Iida K and Miyazaki K: Gene amplification
CCNE1 is related to poor survival and potential therapeutic target
in ovarian cancer. Cancer. 116:2621–2634. 2010.PubMed/NCBI
|
|
30
|
Kim BJ, Kang KM, Jung SY, Choi HK, Seo JH,
Chae JH, Cho EJ, Youn HD, Qin J and Kim ST: Esco2 is a novel
corepressor that associates with various chromatin modifying
enzymes. Biochem Biophys Res Commun. 372:298–304. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ahuja R, Pinyol R, Reichenbach N, Custer
L, Klingensmith J, Kessels MM and Qualmann B: Cordon-bleu is an
actin nucleation factor and controls neuronal morphology. Cell.
131:337–350. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Nair M, Teng A, Bilanchone V, Agrawal A,
Li B and Dai X: Ovol1 regulates the growth arrest of embryonic
epidermal progenitor cells and represses c-myc transcription. J
Cell Biol. 173:253–264. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Roca H, Hernandez J, Weidner S, McEachin
RC, Fuller D, Sud S, Schumann T, Wilkinson JE, Zaslavsky A, Li H,
et al: Transcription factors OVOL1 and OVOL2 induce the mesenchymal
to epithelial transition in human cancer. PloS One. 8:e767732013.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Schwintzer L, Koch N, Ahuja R, Grimm J,
Kessels MM and Qualmann B: The functions of the actin nucleator
Cobl in cellular morphogenesis critically depend on syndapin I.
Embo J. 30:3147–3159. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Nie W, Xue C, Chen J and Xiu Q:
Secretoglobin 1A member 1 (SCGB1A1)+38A/G polymorphism is
associated with asthma risk: A meta-analysis. Gene. 528:304–308.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Peri A, Cordella-Miele E, Miele L and
Mukherjee AB: Tissue-specific expression of the gene coding for
human Clara cell 10-kD protein, a phospholipase A2-inhibitory
protein. J Clin Invest. 92:2099–2109. 1993. View Article : Google Scholar : PubMed/NCBI
|
